REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Apco Pharma Limited (India)

Main Activities: Office Administrative Services
Full name: Apco Pharma Limited Profile Updated: March 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

apco pharma operates in the pharmaceutical industry, specializing in the manufacturing and supply of a wide range of pharmaceutical products in Indian and international markets. apco pharma develops medicines that address medical needs and also exports pharmaceutical products. Their product range includes hand sanitizer, disinfectant spray, herbal products, and nutraceuticals.

Legal Address
359/25 Ignou Road Saiduljab
South Delhi; Delhi; Postal Code: 110030

Contact Details: Purchase the Apco Pharma Limited report to view the information.

Basic Information
Total Employees:
Purchase the Apco Pharma Limited report to view the information.
Registered Capital:
Purchase the Apco Pharma Limited report to view the information.
Financial Auditors:
Purchase the Apco Pharma Limited report to view the information.
Incorporation Date:
May 18, 1994
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
26.05%
Purchase this report to view the information.
13.7%
Purchase this report to view the information.
11.65%
Company Performance
Financial values in the chart are available after Apco Pharma Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
16.24%▲
Total operating revenue
14.07%▲
Operating Profit/Loss (EBIT)
17.6%▲
EBITDA
16.77%▲
Net Profit/Loss for the Period
77.95%▲
Total Assets
25.46%▲
Total Equity
3.93%▲
Operating Profit Margin (ROS)
0.05%▲
Net Profit Margin
0.41%▲
Return on Equity (ROE)
1.57%▲
Debt/Equity
20.13%▲
Quick Ratio
-0.16%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo